Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Gyan

Showing results (41-50 of 174) with videos related to

Pageof 18
Sort By:
Journal of Medical Case Reports|July 19, 2017
Primary solitary plasmacytoma of the liver - successful treatment with fractionated stereotactic radiotherapy (Cyberknife®): a case reportThomas Chalopin, Isabelle Barillot, Jean-Paul Biny, et al.
Hematology Reports|January 7, 2016
Docosahexaenoic Acid Induces Apoptosis in Primary Chronic Lymphocytic Leukemia CellsRomain Guièze, Emmanuel Gyan, Olivier Tournilhac, et al.
Journal of Medical Case Reports|September 20, 2021
Megaloblastic anemia-related iron overload and erythroid regulators: a case reportNicolas Vallet, Jean-Baptiste Delaye, Martine Ropert, et al.
Cytometry. Part B, Clinical Cytometry|September 5, 2020
Reactive oxygen species levels differentiate CD34<sup>+</sup> human progenitors based on CD38 expressionChristine Vignon, Sébastien Lachot, Amélie Foucault, et al.
Pharmacological Research|May 24, 2016
Endogenous metabolites that are substrates of organic anion transporter's (OATs) predict methotrexate clearanceKienana Muhrez, Isabelle Benz-de Bretagne, Lydie Nadal-Desbarats, et al.
Journal of Medical Case Reports|July 4, 2018
Glycemic dysregulation in a patient with type 2 diabetes treated with 5-azacitidine: a case reportAntoine Ponard, Nicole Ferreira-Maldent, Marjan Ertault, et al.
Clinical Pharmacokinetics|November 13, 2021
The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug DispositionAmina Bensalem, Guillaume Cartron, Ulrich Specks, et al.
Anti-Cancer Drugs|December 16, 2016
Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomasSandrine Aspeslagh, Mark Stein, Rastilav Bahleda, et al.
British Journal of Haematology|March 21, 2014
Could a citrus keep the haematologist away?Benjamin Chaigne, Caroline Dartigeas, Lotfi Benboubker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Obinutuzumab (GA101) in patients with relapsed/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN studyGilles A Salles, Franck Morschhauser, Philippe Solal-Céligny, et al.
Pageof 18

Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
Journal of Medical Case Reports|July 19, 2017
Primary solitary plasmacytoma of the liver - successful treatment with fractionated stereotactic radiotherapy (Cyberknife®): a case reportThomas Chalopin, Isabelle Barillot, Jean-Paul Biny, et al.
Hematology Reports|January 7, 2016
Docosahexaenoic Acid Induces Apoptosis in Primary Chronic Lymphocytic Leukemia CellsRomain Guièze, Emmanuel Gyan, Olivier Tournilhac, et al.
Journal of Medical Case Reports|September 20, 2021
Megaloblastic anemia-related iron overload and erythroid regulators: a case reportNicolas Vallet, Jean-Baptiste Delaye, Martine Ropert, et al.
Cytometry. Part B, Clinical Cytometry|September 5, 2020
Reactive oxygen species levels differentiate CD34<sup>+</sup> human progenitors based on CD38 expressionChristine Vignon, Sébastien Lachot, Amélie Foucault, et al.
Pharmacological Research|May 24, 2016
Endogenous metabolites that are substrates of organic anion transporter's (OATs) predict methotrexate clearanceKienana Muhrez, Isabelle Benz-de Bretagne, Lydie Nadal-Desbarats, et al.
Journal of Medical Case Reports|July 4, 2018
Glycemic dysregulation in a patient with type 2 diabetes treated with 5-azacitidine: a case reportAntoine Ponard, Nicole Ferreira-Maldent, Marjan Ertault, et al.
Clinical Pharmacokinetics|November 13, 2021
The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug DispositionAmina Bensalem, Guillaume Cartron, Ulrich Specks, et al.
Anti-Cancer Drugs|December 16, 2016
Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomasSandrine Aspeslagh, Mark Stein, Rastilav Bahleda, et al.
British Journal of Haematology|March 21, 2014
Could a citrus keep the haematologist away?Benjamin Chaigne, Caroline Dartigeas, Lotfi Benboubker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Obinutuzumab (GA101) in patients with relapsed/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN studyGilles A Salles, Franck Morschhauser, Philippe Solal-Céligny, et al.
Pageof 18